Frontotemporal dementia (FTD) is a progressive brain disorder that affects the frontal and temporal lobes of the brain. These lobes are responsible for personality, behavior, and language. FTD typically occurs in people between the ages of 40 and 65, and it is estimated that about 50,000 to 60,000 people in the United States have the disease.
FTD is a type of dementia, but it differs from other types of dementia, such as Alzheimer's disease, in several ways. One of the most significant differences is that FTD typically affects younger people. Another difference is that FTD often affects behavior and personality, whereas Alzheimer's disease primarily affects memory.
There are three main types of FTD: behavioral variant FTD (bvFTD), semantic dementia, and progressive nonfluent aphasia (PNFA). The symptoms of each type can vary, but they all involve changes in behavior, personality, or language.
BvFTD is the most common type of FTD, accounting for about 60% of cases. It typically affects a person's behavior and personality, causing them to become impulsive, socially inappropriate, and lacking in empathy. People with bvFTD may also experience changes in their eating habits, such as overeating or developing a preference for sweet foods.
Semantic dementia is less common than bvFTD and affects a person's ability to understand and use language. People with this type of FTD may have difficulty finding the right words to express themselves or understanding the meaning of words and phrases. They may also have difficulty recognizing familiar people or objects.
PNFA affects a person's ability to speak or write, and they may have difficulty producing or understanding language. People with PNFA may speak slowly or struggle to form sentences. They may also have difficulty with grammar or using the correct words.
The cause of FTD is not fully understood, but it is thought to be related to the buildup of abnormal proteins in the brain. These proteins, called tau and TDP-43, form clumps that damage and kill brain cells. In some cases, FTD is caused by genetic mutations that affect the production of these proteins.
There is currently no cure for FTD, and treatment is focused on managing symptoms. Medications may be prescribed to help with mood or behavior changes, and speech therapy may be helpful for people with language difficulties. Caregiver support is also important, as FTD can be challenging for both the person with the disease and their loved ones.
In conclusion, frontotemporal dementia is a progressive brain disorder that primarily affects behavior, personality, and language. While there is currently no cure, treatment and support can help manage symptoms and improve quality of life for people with FTD and their caregivers.

